0.00Open25.67Pre Close0 Volume1 Open Interest45.00Strike Price0.00Turnover241.22%IV-7.37%PremiumDec 20, 2024Expiry Date31.29Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9852Delta0.0019Gamma2.41Leverage Ratio-0.0758Theta0.0050Rho2.37Eff Leverage0.0031Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet